ACCESSION: MSBNK-SMB_Measured-HSA015P0302001
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'EL03_pos_8986': {'bp': 229756.0, 'sum': 726975.0}, 'Blanc1-pos_9417': {'bp': 221664.0, 'sum': 705846.0}, 'EL02_pos_9172': {'bp': 105336.0, 'sum': 301213.0}, 'EL06_pos_9125': {'bp': 102005.0, 'sum': 315605.0}, 'EL23_pos_9095': {'bp': 96646.0, 'sum': 287051.0}, 'EL20_pos_9088': {'bp': 96032.0, 'sum': 294350.0}, 'EL04_pos_9083': {'bp': 95916.0, 'sum': 300425.0}, 'EL24_pos_9089': {'bp': 95338.0, 'sum': 286231.0}, 'EL15_pos_9124': {'bp': 94968.0, 'sum': 288071.0}, 'EL17_pos_9113': {'bp': 92028.0, 'sum': 278506.0}, 'EL16_pos_9095': {'bp': 88759.0, 'sum': 277614.0}, 'EL07_pos_9089': {'bp': 88012.0, 'sum': 269647.0}, 'EL08_pos_9095': {'bp': 86165.0, 'sum': 263798.0}, 'Blanc2-pos_8993': {'bp': 83842.0, 'sum': 270558.0}}
COMMENT: RETENTION_TIME_STDEV 0.030
COMMENT: PRECURSOR_M/Z_RAW 302.247851
COMMENT: PRECURSOR_M/Z_STDEV 0.000124
COMMENT: PRECURSOR_IN_MS1 mz 302.247844; int 45.627; delta(ppm) 1.335252
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+NH4; mz 237.221246; int 2.616; cor 0.709
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.013; C20H31NO; [M+H]+; delta(ppm) 0.013278
COMMENT: PROPOSED_MF SevenGoldenRules 3.446; C14H32N5P; [M+H]+; delta(ppm) 3.445751
COMMENT: PROPOSED_MF SevenGoldenRules 4.754; C10H26N3P; [M+2ACN+H]+; delta(ppm) 4.753921
COMMENT: PROPOSED_MF MS-FINDER 4.645; C20H31NO; [M+H]+; delta(ppm) 0.013068
COMMENT: PROPOSED_MF SIRIUS5_Sirius 8.854; C20H31NO; [M+H]+; delta(ppm) 0.013068
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C20H31NO; [M+H]+; delta(ppm) 0.013068
COMMENT: PROPOSED_MF SIRIUS6_Sirius 11.061; C20H31NO; [M+H]+; delta(ppm) 0.013068
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.754; C14H31BN2O4; [M+H]+; delta(ppm) 34260.658379
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.426; C17H32FNO2; [M+H]+; delta(ppm) -3.767437
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.333; C18H29N4; [M+H]+; delta(ppm) 4.455348
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.333; C14H23N2; [M+C4H6N2+H]+; delta(ppm) 4.455348
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.087; C17H33O4; [M+H]+; delta(ppm) 8.880299
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.153; C14H32N5P; [M+H]+; delta(ppm) 3.432659
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.153; C10H26N3P; [M+C4H6N2+H]+; delta(ppm) 3.432659
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.484; C16H34N2OP; [M+H]+; delta(ppm) -1.009612
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.484; C12H28OP; [M+C4H6N2+H]+; delta(ppm) -1.009612
COMMENT: PROPOSED_MF SIRIUS6_Sirius -6.049; C15H33N4S; [M+H]+; delta(ppm) -6.698147
COMMENT: PROPOSED_MF SIRIUS6_Sirius -6.049; C11H27N2S; [M+C4H6N2+H]+; delta(ppm) -6.698147
COMMENT: PROPOSED_MF SIRIUS6_Sirius -6.568; C3H25N16O; [M+H]+; delta(ppm) 2.792518
COMMENT: PROPOSED_MF SIRIUS6_Sirius -8.785; CH23N19; [M+H]+; delta(ppm) 7.234823
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.992; C20H31NO; [M+H]+; delta(ppm) 0.013068
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.971; C14H23N2; [M+C4H6N2+H]+; delta(ppm) 4.455348
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.017; C10H26N3P; [M+C4H6N2+H]+; delta(ppm) 3.432659
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.010; C12H28OP; [M+C4H6N2+H]+; delta(ppm) -1.009612
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.005; C14H31BN2O4; [M+H]+; delta(ppm) 34260.658379
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.003; C17H32FNO2; [M+H]+; delta(ppm) -3.767437
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.003; C11H27N2S; [M+C4H6N2+H]+; delta(ppm) -6.698147
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.640; HWHLPVGTWGOCJO-UHFFFAOYSA-N; [M+H]+; OC(CCN1CCCCC1)(C1CCCCC1)C1=CC=CC=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.403; CCDHTPVHZBYPLL-UHFFFAOYSA-N; [M+H]+; ON=C1C(=C2CC3CC2C(C)C3(C)C)C4CC1C(C)C4(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.373; HOPILPCNVMYYFM-YNISYDSXNA-N; [M+H]+; CC1=CCN2[C@H]1C[C@H]1[C@@]2(C)CC[C@]2(CO)C(C)=CCC[C@]12C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.333; ANTKBACNWQHQJE-UHFFFAOYSA-N; [M+H]+; CCCCC1CCN(CC1)CCCC(=O)C2=CC=CC=C2C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.327; YMYZFEUFVGKZEM-UHFFFAOYSA-N; [M+H]+; O=C1C(=C(N2CC3(C)CC2CC(C)(C)C3)C)C4C(C1)C4(C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.927; HWHLPVGTWGOCJO-UHFFFAOYSA-N; [M+H]+; Trihexyphenidyl
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.629; HOPILPCNVMYYFM-YNISYDSXNA-N; [M+H]+; Thelepogine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.462; CCDHTPVHZBYPLL-UHFFFAOYSA-N; [M+H]+; N-(5,5,6-trimethyl-3-{5,5,6-trimethylbicyclo[2.2.1]heptan-2-ylidene}bicyclo[2.2.1]heptan-2-ylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.271; YMYZFEUFVGKZEM-UHFFFAOYSA-N; [M+H]+; 6,6-dimethyl-2-(1-{1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl}ethylidene)bicyclo[3.1.0]hexan-3-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.798; OIPHBJBKSAKTTI-IVZWYUIFSA-N; [M+H]+; (E,E,E)-N-(2-Methylproyl)hexadeca-2,6,8-trien-10-ynamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.793; NSUCVRFWGHUDPG-YNMXRFAKSA-N; [M+H]+; UNPD100231
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.733; JCHRJESAIGMVCT-BNFZFUHLSA-N; [M+H]+; UNPD65242
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.674; DGNHWXGTSUFJLD-YNMXRFAKSA-N; [M+H]+; UNPD165951
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.601; ANTKBACNWQHQJE-UHFFFAOYSA-N; [M+H]+; 4-(4-butylpiperidin-1-yl)-1-(2-methylphenyl)butan-1-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.595; QOBGWWQAMAPULA-RLLQIKCJSA-N; [M+H]+; N,N-dimethyl-2-[[(1R,2S,4R)-1,7,7-trimethyl-2-phenyl-2-bicyclo[2.2.1]heptanyl]oxy]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; HWHLPVGTWGOCJO-UHFFFAOYSA-N; [M+H]+; Trihexyphenidyl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.973; HOPILPCNVMYYFM-YNISYDSXNA-N; [M+H]+; Thelepogine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.944; YMYZFEUFVGKZEM-UHFFFAOYSA-N; [M+H]+; 6,6-dimethyl-2-(1-{1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl}ethylidene)bicyclo[3.1.0]hexan-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.784; DGNHWXGTSUFJLD-YNMXRFAKSA-N; [M+H]+; UNPD165951
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.784; JCHRJESAIGMVCT-BNFZFUHLSA-N; [M+H]+; UNPD65242
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.765; ANTKBACNWQHQJE-UHFFFAOYSA-N; [M+H]+; 4-(4-butylpiperidin-1-yl)-1-(2-methylphenyl)butan-1-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.538; OIPHBJBKSAKTTI-IVZWYUIFSA-N; [M+H]+; (E,E,E)-N-(2-Methylproyl)hexadeca-2,6,8-trien-10-ynamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.133; NSUCVRFWGHUDPG-YNMXRFAKSA-N; [M+H]+; UNPD100231
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; QOBGWWQAMAPULA-RLLQIKCJSA-N; [M+H]+; N,N-dimethyl-2-[[(1R,2S,4R)-1,7,7-trimethyl-2-phenyl-2-bicyclo[2.2.1]heptanyl]oxy]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; CCDHTPVHZBYPLL-UHFFFAOYSA-N; [M+H]+; N-(5,5,6-trimethyl-3-{5,5,6-trimethylbicyclo[2.2.1]heptan-2-ylidene}bicyclo[2.2.1]heptan-2-ylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.979; HWHLPVGTWGOCJO-UHFFFAOYSA-N; [M+H]+; 1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; ILZMSGCLOKHJRT-UHFFFAOYSA-N; [M+H]+; 1-[(4-prop-2-enoxy-3,5-dipropylphenyl)methyl]pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.068; FYVHUDCCDVZFBU-UHFFFAOYSA-N; [M+H]+; 4-cyclohexyl-2-[(3,5-dimethylpiperidin-1-yl)methyl]phenol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.923; ASTSSGAIOAXHCU-UHFFFAOYSA-N; [M+H]+; 1-[2-(2,2-dimethyl-4-phenyloxan-4-yl)ethyl]piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.912; RLJSPSXYQAOQAZ-OXJNMPFZSA-N; [M+H]+; (4bS,8aS)-3-amino-4b,8,8-trimethyl-1-propan-2-yl-5,6,7,8a,9,10-hexahydrophenanthren-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.770; QOBGWWQAMAPULA-RLLQIKCJSA-N; [M+H]+; N,N-dimethyl-2-[[(1R,2S,4R)-1,7,7-trimethyl-2-phenyl-2-bicyclo[2.2.1]heptanyl]oxy]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.143; JEWCXPGDBLFXNE-UHFFFAOYSA-N; [M+H]+; 4-[2,4-bis(2-methylbutan-2-yl)phenoxy]butanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.143; UFXYNOGUHPZYQF-UHFFFAOYSA-N; [M+H]+; 1-[2-[cyclohexyl(phenyl)methoxy]ethyl]piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.143; YFJLAYHWAFXYCK-UHFFFAOYSA-N; [M+H]+; 1-[3-(1-phenylcyclohexyl)oxypropyl]piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.339; HWHLPVGTWGOCJO; [M+H]+; Cyclodol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -168.760; ANTKBACNWQHQJE; [M+H]+; 4-(4-butyl-1-piperidyl)-1-(o-tolyl)butan-1-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -212.457; DGNHWXGTSUFJLD; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -215.851; JCHRJESAIGMVCT; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -224.985; FRBBPWXCRBHYJQ; [M+H]+; Tricyclamol cation
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -229.032; ASTSSGAIOAXHCU; [M+H]+; 1-[2-(2,2-dimethyl-4-phenyloxan-4-yl)ethyl]piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -238.326; FYVHUDCCDVZFBU; [M+H]+; 4-Cyclohexyl-alpha-(3,5-dimethylpiperidino)-o-cresol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -257.439; NSUCVRFWGHUDPG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -260.212; DVTDUTYENPZLFP; [M+H]+; 3-Ohacn
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -275.090; JEWCXPGDBLFXNE; [M+H]+; 4-(2,4-di-tert-amylphenoxy)butyronitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -295.768; OIPHBJBKSAKTTI; [M+H]+; N-(2-methylpropyl)hexadeca-2,6,8-trien-10-ynamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -319.320; QOBGWWQAMAPULA; [M+H]+; Deramciclane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -366.912; CCDHTPVHZBYPLL; [M+H]+; Oprea1_806909
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -413.300; YMYZFEUFVGKZEM; [M+H]+; 6,6-dimethyl-4-[1-(3,3,5-trimethyl-7-azabicyclo[3.2.1]octan-7-yl)ethylidene]bicyclo[3.1.0]hexan-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -420.602; HOPILPCNVMYYFM; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.345; HWHLPVGTWGOCJO; [M+H]+; Cyclodol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -68.203; UTFUAMIPQAQYSE; [M+C4H6N2+H]+; 1-N,1-N,1-N',1-N',1-N,1-N-hexamethyl-1lambda5-phospholane-1,1,1-triamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -69.892; VRHREDMVTKBOGT; [M+C4H6N2+H]+; Butyl-tris(dimethylamino)phosphanium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -87.614; GYBVIIMUVULJDE; [M+C4H6N2+H]+; N-[diethylamino(dimethylamino)phosphanyl]-N-ethylethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -96.150; ZRZVDNTUZSZQPL; [M+C4H6N2+H]+; N-[bis(dimethylamino)phosphanyl]-N-propan-2-ylpropan-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -120.527; ZQPWGXPIFSZQJS; [M+C4H6N2+H]+; 1-N,1-N,1-N',1-N',1-N,1-N-hexamethyl-4-phosphanylbutane-1,1,1-triamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -124.113; ORXMVWLVKDEHKV; [M+C4H6N2+H]+; N-[bis(dimethylamino)phosphanyl]-N-propylpropan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -157.468; OPHFHNGXBNQARP; [M+C4H6N2+H]+; N'-dimethylphosphinimyl-N,N'-dipropylethane-1,2-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -168.023; SEHWFRTZJBCDHJ; [M+C4H6N2+H]+; 1-N,1-N,1-N',1-N',2-N,2-N-hexamethyl-1-phosphanylbutane-1,1,2-triamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -197.486; DBLADMZNFWSPBT; [M+C4H6N2+H]+; N'-[4-(3-aminopropylphosphanyl)butyl]propane-1,3-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.632; WTNXPCFKMDNWGK; [M+C4H6N2+H]+; N,N,N'-trimethyl-N'-[3-[methyl(phosphanyl)amino]propyl]propane-1,3-diamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -239.201; NSUCVRFWGHUDPG; [M+H]+; Hexadeca-2E,7Z-Dienoic Acid Pyrrolide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -254.042; DGNHWXGTSUFJLD; [M+H]+; Hexadeca-2E,7Z-Diene-10-Ynoic Acid Pyrrolidide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -263.554; OIPHBJBKSAKTTI; [M+H]+; N-(2-methylpropyl)hexadeca-2,6,8-trien-10-ynamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -278.881; JCHRJESAIGMVCT; [M+H]+; Hexadeca-6E,8E-Diene-10-Ynoic Acid Pyrrolidide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -287.108; YMYZFEUFVGKZEM; [M+H]+; 6,6-dimethyl-2-(1-{1,3,3-trimethyl-6-azabicyclo[3.2.1]octan-6-yl}ethylidene)bicyclo[3.1.0]hexan-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -325.781; CCDHTPVHZBYPLL; [M+H]+; N-(5,5,6-trimethyl-3-{5,5,6-trimethylbicyclo[2.2.1]heptan-2-ylidene}bicyclo[2.2.1]heptan-2-ylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -353.074; ASTSSGAIOAXHCU; [M+H]+; 1-(2-(Tetrahydro-2,2-dimethyl-4-phenyl-2H-pyran-4-yl)ethyl)piperidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -397.709; DVTDUTYENPZLFP; [M+H]+; 3alpha-Hydroxy-5beta-androstane-17beta-carbonitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -406.488; HWHLPVGTWGOCJO; [M+H]+; 1-cyclohexyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -407.269; JEWCXPGDBLFXNE; [M+H]+; 4-(2,4-Di-tert-pentylphenoxy)butanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.161; NSUCVRFWGHUDPG; [M+H]+; Hexadeca-2E,7Z-Dienoic Acid Pyrrolide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.057; UTFUAMIPQAQYSE; [M+C4H6N2+H]+; 1-N,1-N,1-N',1-N',1-N,1-N-hexamethyl-1lambda5-phospholane-1,1,1-triamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C20H32N1O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 14.818
MS$FOCUSED_ION: PRECURSOR_M/Z 302.247845
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0udi-0189000000-93eb82db99bd91e2476e
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.0653357 29.1087 58.066056 1.5328 11.24 -0.3818 10 f{C3H8N1}/3.62ppm,p-C17H24O1
  113.0597098 23.5051 113.060209 1.3798 8.76 0.2727 10 ?
  119.0729906 77.7197 119.073439 1.3185 9.60 0.3670 14 f{C8H9N1}/0.34ppm,p-C12H23O1
  132.1019400 167.3418 132.102250 0.6510 36.94 0.4066 14 ?
  204.1746404 943.9434 204.175081 0.3918 53.80 0.8022 14 f{C14H22N1}/-0.17ppm,p-C6H10O1
  205.1780412 113.2598 205.178479 1.2721 15.92 0.7902 12 ?
  230.1910000 43.3986 230.191365 1.2033 8.85 0.6154 12 f{C16H24N1}/2.93ppm,p-C4H8O1
  232.2059143 81.2803 232.206272 1.3135 11.49 0.6319 13 f{C16H26N1}/-0.27ppm,p-C4H6O1
  302.1974730 124.1914 302.197884 0.8670 20.10 0.0545 11 ?
  302.2477657 999.0000 302.248176 0.4003 7.42 1.0000 14 f{C20H32N1O1}/-0.25ppm,p
  303.2511029 182.8982 303.251514 1.3058 14.79 0.7714 14 ?
PK$NUM_PEAK: 11
PK$PEAK: m/z int. rel.int.
  58.065336 29.11 29
  113.059710 23.51 23
  119.072991 77.72 77
  132.101940 167.34 167
  204.174640 943.94 943
  205.178041 113.26 113
  230.191000 43.40 43
  232.205914 81.28 81
  302.197473 124.19 124
  302.247766 999.00 999
  303.251103 182.90 182
//
